JP2025507359A5 - - Google Patents
Info
- Publication number
- JP2025507359A5 JP2025507359A5 JP2024547456A JP2024547456A JP2025507359A5 JP 2025507359 A5 JP2025507359 A5 JP 2025507359A5 JP 2024547456 A JP2024547456 A JP 2024547456A JP 2024547456 A JP2024547456 A JP 2024547456A JP 2025507359 A5 JP2025507359 A5 JP 2025507359A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- composition according
- dbs
- cbr
- cargo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263308776P | 2022-02-10 | 2022-02-10 | |
| US63/308,776 | 2022-02-10 | ||
| PCT/US2023/062270 WO2023154788A2 (en) | 2022-02-10 | 2023-02-09 | Enhanced dna dendrimers and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025507359A JP2025507359A (ja) | 2025-03-18 |
| JP2025507359A5 true JP2025507359A5 (https=) | 2026-02-17 |
Family
ID=87565106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547456A Pending JP2025507359A (ja) | 2022-02-10 | 2023-02-09 | 増強されたｄｎａデンドリマー及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230338557A1 (https=) |
| EP (1) | EP4475891A2 (https=) |
| JP (1) | JP2025507359A (https=) |
| CN (1) | CN119095602A (https=) |
| AU (1) | AU2023217717A1 (https=) |
| CA (1) | CA3243817A1 (https=) |
| IL (1) | IL314724A (https=) |
| WO (1) | WO2023154788A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL314724A (en) * | 2022-02-10 | 2024-10-01 | Code Biotherapeutics Inc | Improved DNA dendrimers and methods of using them |
| WO2025034978A1 (en) * | 2023-08-09 | 2025-02-13 | Code Biotherapeutics, Inc. | Enhanced dna dendrimers and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2950825B1 (en) * | 2013-02-01 | 2019-09-11 | Genisphere, LLC | Functionalized dna dendrimers for gene delivery to cells |
| CN109844134B (zh) * | 2016-08-16 | 2023-05-05 | 塔驰莱特Ip有限公司 | 闭合线性dna的生产 |
| KR20220133999A (ko) * | 2020-01-31 | 2022-10-05 | 타이리스 테라뷰틱스, 에스.엘. | 변형된 뉴클레오티드들을 갖는 닫힌 선형 dna |
| IL314724A (en) * | 2022-02-10 | 2024-10-01 | Code Biotherapeutics Inc | Improved DNA dendrimers and methods of using them |
-
2023
- 2023-02-09 IL IL314724A patent/IL314724A/en unknown
- 2023-02-09 EP EP23753652.9A patent/EP4475891A2/en active Pending
- 2023-02-09 WO PCT/US2023/062270 patent/WO2023154788A2/en not_active Ceased
- 2023-02-09 US US18/166,688 patent/US20230338557A1/en active Pending
- 2023-02-09 AU AU2023217717A patent/AU2023217717A1/en active Pending
- 2023-02-09 CN CN202380021051.XA patent/CN119095602A/zh active Pending
- 2023-02-09 CA CA3243817A patent/CA3243817A1/en active Pending
- 2023-02-09 JP JP2024547456A patent/JP2025507359A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ikeda et al. | Ligand-targeted delivery of therapeutic siRNA | |
| Uherek et al. | DNA-carrier proteins for targeted gene delivery | |
| EP4058032A1 (en) | Compositions for delivery of antisense compounds | |
| JP2014504150A5 (https=) | ||
| US20020115824A1 (en) | Receptor-mediated uptake of peptides that bind the human transferrin receptor | |
| JP2025507359A5 (https=) | ||
| US20190022240A1 (en) | Design of pH-Sensitive Oligopeptide Complexes For Drug Release Under Mildly Acidic Conditions | |
| EP1272221A2 (en) | Peptide conjugates for drug delivery | |
| US20220331441A1 (en) | Tumor-Targeting Polypeptide Nanoparticle Delivery System for Nucleic Acid Therapeutics | |
| CN114870026A (zh) | 一种以ACE2靶向递送shRNA的ACE2siRNA药物制备方法 | |
| US20150374844A1 (en) | Novel ph -switchable peptides for membrane insertion and pore formation | |
| US10640539B2 (en) | Recombinant protein-based method for the delivery of silencer RNA to target the brain | |
| CN118922446A (zh) | 抗b7-h3化合物及使用方法 | |
| US12600764B2 (en) | Antigen-binding proteins targeting coronavirus (COV) variants | |
| Sanclimens et al. | Synthesis and screening of a small library of proline‐based biodendrimers for use as delivery agents | |
| KR20220117091A (ko) | 생체내 세포에서 합성 및 분비되고 세포로 투과하는 관심 폴리펩타이드를 코딩하는 발현카세트 및 이의 용도 | |
| US20050181474A1 (en) | Transport peptides and uses therefor | |
| Brokx et al. | Peptide-and polymer-based gene delivery vehicles | |
| Krhac Levacic et al. | Solid-phase supported design of carriers for therapeutic nucleic acid delivery | |
| EP1788082B1 (en) | Nucleic acid construct | |
| US20250304623A1 (en) | Peptides for intracellular delivery | |
| Vivès et al. | The tat-derived cell-penetrating peptide | |
| Alleva et al. | Functionalizing Nucleic Acids: Synthesis and Purification Strategies for Bioconjugates as Biomaterials | |
| Wang et al. | Mass spectrometric detection of targeting peptide bioconjugation to Red clover necrotic mosaic virus | |
| CN118922445A (zh) | 抗b7-h3化合物及使用方法 |